Chemours (CC) Capital Expenditures (2014 - 2026)

Chemours has reported Capital Expenditures for 13 years, with the latest figure at $27.0 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 3.85% year-over-year to $27.0 million; the trailing twelve-month figure through Mar 2026 stood at $214.0 million (up 1683.33% YoY), and the FY2025 full-year result was $213.0 million, up 142.05% from the prior year.
• Capital Expenditures for Q1 2026 stood at $27.0 million, down from $45.0 million in the prior quarter.
• The five-year high for Capital Expenditures was $265.0 million in Q4 2022, with the low at -$163.0 million in Q4 2024.
• Average Capital Expenditures over 5 years is $44.8 million, with a median of $41.0 million recorded in 2022.
• Peak annual rise in Capital Expenditures reached 383.56% in 2024, while the deepest fall reached 2816.67% in 2024.
• Tracing CC's Capital Expenditures over 5 years: stood at $265.0 million in 2022, then sank by 97.74% to $6.0 million in 2023, then slumped by 2816.67% to -$163.0 million in 2024, then soared by 127.61% to $45.0 million in 2025, then sank by 40.0% to $27.0 million in 2026.
• The last three Capital Expenditures figures came in at $27.0 million (Q1 2026), $45.0 million (Q4 2025), and $142.0 million (Q3 2025), per Business Quant data.

Peer Comparison